How much is a cancer medication worth? Now there are new tools that can help answer this vexing question. A website serves as an online calculator that can compare the cost of 54 cancer drugs. Meanwhile, the American Society of Clinical Oncology is busy creating software-based tools to help choose the most effective therapy.
Recall that television itself, invented in the 1920s, did not conquer living rooms until the 1950s. With videoconferencing, text messaging, email, and the good old phone call, a treatment method that spent many years in the desert has now reached an oasis of acceptance—and savings may result.
With intensivists in short supply, the cost of maintaining a fully staffed ICU extremely high, and an aging population that is likely to mean a growing demand for ICU care, hospitals have turned to telemedicine to staff their ICUs. Will it work?
When infusion therapy, for example, is given at home—a less costly setting—both patient comfort and health plans’ bottom lines benefit. But if hospitals buy up all the practices, health plans and their beneficiaries may lose the chance to save.
What’s not to like about HSAs? They are tax-free accounts that employees can maintain throughout life. And because they are tax-free, the IRS regulates the design of the health plans that go along with them, so they have minimum deductibles and out-of-pocket limits. People are saying, “Where do I sign?”
More aggressive treatment of blood pressure in patients with proteinuric renal disease may be one explanation for the number of new cases of ESRD leveling off. Meanwhile, though, the number of Americans with chronic kidney disease is expected to jump to 16.7% by 2030, or about 38 million people.
Federal government statistics show that ESRD incidence has plateaued in recent years after decades of increases. More aggressive treatment of blood pressure in patients with proteinuric renal disease may be one explanation for the number of new cases of ESRD leveling off. ESRD patients are living longer, so the prevalence of ESRD is increasing.
Hospital and doctor efficiency measures do not effectively link cost and quality, so the gated approach—which measures quality and cost separately—is used. Is that efficient or does another method need to be developed? Researchers say that large employers want some answers to this problem.
Chief Justice John Roberts
Court challenges have failed. Repeal bills will be vetoed. The next major chapter in the ACA’s history may depend on who wins the White House next year.
Jonathan Weiner, PhD
Health insurers’ capability to gather and create data far outstrips their ability to analyze the information and put it to use. Progress is being made.
Sanovas’s MicroCam bronchoscope
With low-dose CT screening for lung cancer, now may be the time for a California company’s smaller, possibly less expensive bronchoscopy technology.